This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): INTUVAX, Combig-DC, Allogeneic dendritic cell
Description: INTUVAX is based on dendritic cells injected intratumorally to ilicit an immune response as a primer to further treatment.
Additional information available to subscribers only: